PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 29, 2021SHILAP Revista de lepidopterología5 citationsOpen Access

The differences between insulin glargine U300 and insulin degludec U100 in impact on the glycaemic variability, arterial stiffness and the lipid profiles in insulin naïve patients suffering from type two diabetes mellitus – outcomes from cross‐over open-label randomized trial

PCPavle Vrebalov CindroMKMladen KrnićDMDarko Modun

Key Points

Key points are not available for this paper at this time.

Abstract

Clinicaltrials.gov, NCT04692415 . Retrospectively registered on December 31th 2020.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Cindro et al. (2021) studied this question.

synapsesocial.com/papers/69da26060f32475823a3d25ehttps://doi.org/10.1186/s12902-021-00746-1
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Noninvasive Assessment of Arterial Stiffness and Risk of Atherosclerotic Events2003 · 824 citations
  2. 2Insulin Detemir Offers Improved Glycemic Control Compared With NPH Insulin in People With Type 1 Diabetes2004 · 257 citations
  3. 3Glycemic markers and relation with arterial stiffness in Caucasian subjects of the MARK study2017 · 33 citations
  4. 4Effect of insulin analog initiation therapy on LDL/HDL subfraction profile and HDL associated enzymes in type 2 diabetic patients2013 · 46 citations
  5. 5Glycemic Variability: The Third Component of the Dysglycemia in Diabetes. Is it Important? How to Measure it?2008 · 295 citations